GB1435384A - Psychopharmacologically active peptides - Google Patents

Psychopharmacologically active peptides

Info

Publication number
GB1435384A
GB1435384A GB2298473A GB2298473A GB1435384A GB 1435384 A GB1435384 A GB 1435384A GB 2298473 A GB2298473 A GB 2298473A GB 2298473 A GB2298473 A GB 2298473A GB 1435384 A GB1435384 A GB 1435384A
Authority
GB
United Kingdom
Prior art keywords
boc
phe
lys
otbu
glu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2298473A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of GB1435384A publication Critical patent/GB1435384A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C07K5/06095—Arg-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C07K14/6955—Corticotropin [ACTH] with at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB2298473A 1972-05-24 1973-05-15 Psychopharmacologically active peptides Expired GB1435384A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NLAANVRAGE7206941,A NL175988C (nl) 1972-05-24 1972-05-24 Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat dat afgeleid is van een de aminozuren 4-10 omvattend, fragment van adrenocorticotroop hormoon als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.

Publications (1)

Publication Number Publication Date
GB1435384A true GB1435384A (en) 1976-05-12

Family

ID=19816103

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2298473A Expired GB1435384A (en) 1972-05-24 1973-05-15 Psychopharmacologically active peptides

Country Status (13)

Country Link
US (1) US3850904A (cg-RX-API-DMAC7.html)
JP (1) JPS5747667B2 (cg-RX-API-DMAC7.html)
AU (1) AU470908B2 (cg-RX-API-DMAC7.html)
BE (1) BE799939A (cg-RX-API-DMAC7.html)
CA (1) CA1030954A (cg-RX-API-DMAC7.html)
CH (1) CH587229A5 (cg-RX-API-DMAC7.html)
DE (1) DE2326033C2 (cg-RX-API-DMAC7.html)
FR (1) FR2185412B1 (cg-RX-API-DMAC7.html)
GB (1) GB1435384A (cg-RX-API-DMAC7.html)
HU (1) HU169159B (cg-RX-API-DMAC7.html)
NL (1) NL175988C (cg-RX-API-DMAC7.html)
SE (1) SE407215B (cg-RX-API-DMAC7.html)
ZA (1) ZA733211B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438029A (en) 1978-01-19 1984-03-20 Research Corporation Synthetic peptides
US4356119A (en) * 1978-09-28 1982-10-26 Nordisk Insulinlaboratorium Therapeutically active polypeptides or acid addition salts and a process for producing such compounds
NL8101724A (nl) * 1981-04-08 1982-11-01 Akzo Nv Peptiden met zenuw-regenererende eigenschappen.
US4500713A (en) * 1982-09-23 1985-02-19 Usv Pharmaceutical Corporation Therapeutic dipeptides
NZ214543A (en) * 1984-12-14 1990-03-27 Australian Commercial Research Amino acid and peptide derivatives that inhibit human leucocytic elastase enzyme (hle)
US20130059914A1 (en) 2010-04-21 2013-03-07 Signature Therapeutics, Inc. Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof
CN117715632A (zh) 2021-03-09 2024-03-15 恩赛斯生物科学股份有限公司 包含酶可裂解的前药和萘莫司他的组合物及其使用方法
KR20230174213A (ko) 2021-03-09 2023-12-27 엔사이스 바이오사이언시즈 인크. 나파모스타트의 변형된 방출 조성물 및 그의 사용 방법
MX2024003466A (es) 2021-09-29 2024-06-04 Ensysce Biosciences Inc Profarmacos de metadona escindibles por enzimas y metodos de uso de los mismos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1302396A (fr) * 1961-03-10 1962-08-31 Ciba Geigy Procédés de préparation de nouveaux heptapeptides de formule l-alpha-[mercaptoalcoyl (inférieur)]-alpha-amino-acétyl-l-glutaminyl-l-histidyl-l-phényl alanyl-l-alpha-[amino-alcoyl (inférieur)]-alpha-amino-acétyl-l-tryptophyl glycine
NL6509727A (cg-RX-API-DMAC7.html) * 1965-07-28 1967-01-30
GB1301738A (cg-RX-API-DMAC7.html) * 1969-07-09 1973-01-04

Also Published As

Publication number Publication date
NL175988B (nl) 1984-09-03
DE2326033A1 (de) 1973-12-20
BE799939A (fr) 1973-11-23
SE407215B (sv) 1979-03-19
NL175988C (nl) 1985-02-01
JPS4948666A (cg-RX-API-DMAC7.html) 1974-05-11
AU470908B2 (en) 1976-04-01
US3850904A (en) 1974-11-26
JPS5747667B2 (cg-RX-API-DMAC7.html) 1982-10-12
HU169159B (cg-RX-API-DMAC7.html) 1976-10-28
FR2185412A1 (cg-RX-API-DMAC7.html) 1974-01-04
DE2326033C2 (de) 1983-10-27
CA1030954A (en) 1978-05-09
FR2185412B1 (cg-RX-API-DMAC7.html) 1976-12-03
NL7206941A (cg-RX-API-DMAC7.html) 1973-11-27
CH587229A5 (cg-RX-API-DMAC7.html) 1977-04-29
ZA733211B (en) 1974-04-24
AU5575073A (en) 1974-11-21

Similar Documents

Publication Publication Date Title
RU96115195A (ru) Соединения со свойствами выделения (высвобождения) гормона роста
KR910006324A (ko) 펩티다아제 및 아이소머라제 억제제
SE8007763L (sv) Sett att framstella en polypeptid
ATE298561T1 (de) Orale dareichungsform
DE3686200D1 (de) Biologisch wirksame lysin enthaltende octapeptide.
FR2281162A1 (fr) Aminoacides n-acyles et derives d'acides amines n-acyles comme agents gelifiants
GB1403642A (en) Nonapeptide amide derivatives
RU94035760A (ru) Опиоидные пептиды
MY135057A (en) Dolastatin 15 derivatives
US4005063A (en) [Des-gly]10 -GnRH nonapeptide anide analogs in position 6 having ovulation-inducing activity
RU2223970C2 (ru) Лечение ожирения
JPS5559152A (en) New peptides with physiological activity and their preparation
DK0437563T3 (da) Bioligiske aktive lægemiddelpolymerderivater
MX9703642A (es) Metodos para el tratamiento de esclerosis multiple utilizando analogos de peptido en la posicion 91 de la proteina basica de mielina humana.
KR940005669A (ko) 사이클로펩타이드, 및 점막에 적용시 흡수 촉진제로서의 이의 용도
EP0563212A1 (en) Synthetic immunoactive peptides having immunomodulating and therapeutic activities
KR910002899A (ko) 혈조절 펩타이드
RU97107089A (ru) Полипептидные соединения, содержащие d-2-алкилтриптофан, стимулирующий высвобождение гормона роста
GB1425099A (en) Psychopharmacologically active peptides
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
NZ335879A (en) Somatostatin antagonist peptides having a D-amino acid at the second residue
GB1309150A (en) Acthactive peptides and process for their manufacture
GB1491017A (en) Peptides
ES272025A1 (es) Procedimiento para la obtenciën de polipepturos nuevos
SE0002232D0 (sv) Antioxidant

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee